Evidence map›Paper›PMID 42548046›Full record

ArticleVirulence2026

Luteolin as a urease inhibitor: A novel therapeutic strategy against

Xingye Wang, Dongyue Zhou, Mingran Li, Xiangri Kong, Shuang Jiang, Qingjie Li, Lin Wei, Lihong Jiang, Wu Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xingye WangCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.ORCID 0009-0002-7034-1639
Dongyue ZhouJiangxi Province Key Laboratory of Traditional Chinese Medicine Pharmacology, Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang, China.
Mingran LiCollege of Integrated Chinese and Western Medicine, Changchun University of Chinese Medicine, Changchun, China.
Xiangri KongEndocrinology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
Shuang JiangSchool of Basic Medicine, Changchun University of Chinese Medicine, Changchun, China.
Qingjie LiResearch Center of Traditional Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
Lin WeiSchool of Basic Medicine, Changchun University of Chinese Medicine, Changchun, China.
Lihong JiangCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Wu SongSchool of Basic Medicine, Changchun University of Chinese Medicine, Changchun, China.ORCID 0000-0002-1314-8018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rising prevalence of antibiotic-resistant

Indexed as

Anti-Bacterial AgentsEnzyme InhibitorsHelicobacter InfectionsHelicobacter pyloriLuteolinUreaseAnimalsBacterial ProteinsCell LineDisease Models, AnimalHumansMiceMolecular Docking SimulationAnti-Bacterial AgentsBacterial ProteinsEnzyme InhibitorsLuteolinUreaseammonia restrictionHelicobacter pyloriluteolinmetabolic disruptionurease

Identifiers

PMID42548046
PMCPMC13449824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.